Omniab Inc Stock Today
| OABI Stock | USD 3.92 0.07 1.82% |
Performance0 of 100
| Odds Of DistressLess than 20
|
OmniAb is trading at 3.92 as of the 24th of November 2024. This is a 1.82% up since the beginning of the trading day. The stock's open price was 3.85. OmniAb has about a 20 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for OmniAb Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of November 2023 and ending today, the 24th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 2nd of November 2022 | Category Healthcare | Classification Health Care |
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company was founded in 2012 and is headquartered in Emeryville, California. Amniab operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 121.01 M outstanding shares of which 7.98 M shares are now shorted by private and institutional investors with about 27.84 trading days to cover. More on OmniAb Inc
Moving against OmniAb Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
OmniAb Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Matthew Foehr | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsOmniAb can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand OmniAb's financial leverage. It provides some insight into what part of OmniAb's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OmniAb Inc (OABI) is traded on NASDAQ Exchange in USA. It is located in 5980 Horton Street, Emeryville, CA, United States, 94608 and employs 106 people. OmniAb is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 474.37 M. OmniAb Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 121.01 M outstanding shares of which 7.98 M shares are now shorted by private and institutional investors with about 27.84 trading days to cover.
OmniAb generates positive cash flow from operations, but has no cash available
Check OmniAb Probability Of Bankruptcy
Ownership AllocationOmniAb owns a total of 121.01 Million outstanding shares. Over half of OmniAb's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check OmniAb Ownership Details
OmniAb Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| State Street Corp | 2024-06-30 | 2 M | |
| First Sabrepoint Capital Management Lp | 2024-09-30 | 1.7 M | |
| Villere St Denis J & Co Llc | 2024-09-30 | 1.5 M | |
| Orchard Capital Management, Llc | 2024-06-30 | 1.4 M | |
| Adar1 Capital Management Llc | 2024-09-30 | 1.3 M | |
| Millennium Management Llc | 2024-06-30 | 1 M | |
| Kornitzer Capital Management Inc | 2024-09-30 | 898.8 K | |
| Northern Trust Corp | 2024-09-30 | 837.3 K | |
| Kent Lake Capital Llc | 2024-06-30 | 800 K | |
| Avista Capital Holdings Lp | 2024-09-30 | 15.8 M | |
| Hhg Plc | 2024-06-30 | 7.9 M |
OmniAb Historical Income Statement
OmniAb Stock Against Markets
OmniAb Corporate Management
| Cia McCaffrey | Vice Talent | Profile | |
| Donna CPA | Senior Controller | Profile | |
| Bill Harriman | Senior Discovery | Profile | |
| Douglas Krafte | Senior Head | Profile | |
| MarieCecile DVM | Senior Genetics | Profile | |
| Charles JD | Chief Secretary | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OmniAb Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OmniAb. If investors know OmniAb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OmniAb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Revenue Per Share 0.202 | Quarterly Revenue Growth (0.24) | Return On Assets (0.14) | Return On Equity (0.20) |
The market value of OmniAb Inc is measured differently than its book value, which is the value of OmniAb that is recorded on the company's balance sheet. Investors also form their own opinion of OmniAb's value that differs from its market value or its book value, called intrinsic value, which is OmniAb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OmniAb's market value can be influenced by many factors that don't directly affect OmniAb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OmniAb's value and its price as these two are different measures arrived at by different means. Investors typically determine if OmniAb is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OmniAb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.